HARP - Harpoon Therapeutics Inc
Close
23.01
0.020 0.087%
Share volume: 0
Last Updated: Fri 08 Mar 2024 10:00:00 PM CET
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$22.99
0.02
0.09%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-12 | 2022-08-10 | 2022-11-14 | 2023-03-27 | 2023-05-11 | 2023-08-09 | 2023-11-09 | |
| Assets | ||||||||
| Total Assets | 132.447 M | 108.951 M | 83.496 M | 73.729 M | 80.809 M | 63.199 M | 47.578 M | |
| Current Assets | 116.945 M | 94.037 M | 69.149 M | 54.727 M | 63.861 M | 49.067 M | 34.296 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 4.480 M | 3.884 M | 3.051 M | 1.615 M | 2.476 M | 3.512 M | 2.688 M | |
| Short Term Investments | 4.480 M | 3.884 M | 3.051 M | 1.615 M | 2.476 M | 3.512 M | 2.688 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 112.465 M | 90.153 M | 66.098 M | 53.112 M | 61.385 M | 45.555 M | 31.608 M | |
| Total Non-current Assets | 15.502 M | 14.914 M | 14.347 M | 19.002 M | 16.948 M | 14.132 M | 13.282 M | |
| Property Plant Equipment | 8.722 M | 8.247 M | 7.917 M | 7.237 M | 5.757 M | 3.672 M | 3.527 M | |
| Other Assets | 6.780 M | 6.667 M | 6.430 M | 11.765 M | 11.191 M | 10.460 M | 9.755 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 132.447 M | 108.951 M | 83.496 M | 73.729 M | 80.809 M | 63.199 M | 47.578 M | |
| Total liabilities | 91.063 M | 82.309 M | 66.584 M | 68.330 M | 80.094 M | 60.201 M | 43.037 M | |
| Total current liabilities | 58.583 M | 58.223 M | 54.061 M | 52.433 M | 44.173 M | 25.334 M | 18.106 M | |
| Accounts Payable | 4.189 M | 2.790 M | 2.640 M | 4.712 M | 4.002 M | 3.627 M | 3.435 M | |
| Other liabilities | 22.386 M | 14.454 M | 3.378 M | 2.314 M | 17.859 M | 15.795 M | 4.574 M | |
| Current long term debt | 1.707 M | 1.767 M | 1.828 M | 2.423 M | 2.789 M | 2.875 M | 2.974 M | |
| Long term debt | 10.094 M | 9.632 M | 9.145 M | 13.583 M | 18.062 M | 19.072 M | 20.357 M | |
| Other liabilities | 22.386 M | 14.454 M | 3.378 M | 2.314 M | 17.859 M | 15.795 M | 4.574 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 41.384 M | 26.642 M | 16.912 M | 5.399 M | 715.000 K | 2.998 M | 4.541 M | |
| Common stock | 3.288 M | 3.304 M | 3.306 M | 3.369 M | 3.697 M | 3.767 M | 39.480 M | |
| Retained earnings | -305.113 M | -322.464 M | -334.104 M | -352.523 M | -363.861 M | -362.801 M | -364.602 M |